Innovation

More Topics

Image of China banknotes with a magnifying glass indicating dealmaking in Asia

Eyes on Asia: BIOSECURE, Merck & Hansoh, Roche adds ADC, and Samsung Eyes on Asia: BIOSECURE, Merck & Hansoh, Roche adds ADC, and Samsung

BioXconomy presents the Asia biopharma and healthcare dealmaking and financing news for the week ending 5 January.

byDan Stanton, Editorial director

Jan 8, 2025

|

1 Min Read

Charles River launches UK incubator program Charles River launches UK incubator program

byMillie Nelson

Dec 28, 2024

1 Min Read

Hervé Ansanay, Biotech Alliance Manager, discusses the features of the RESEAU SATT - SATT NETWORK

RESEAU SATT, the Best of French Deep Tech RESEAU SATT, the Best of French Deep Tech

byBIO-Europe 2024

Dec 18, 2024

3 Min View

Michael May, PhD, President, CCRM discusses Canada as a place for life sciences in this video.

Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move

byBIO-Europe 2024

Dec 18, 2024

8 Min View

Eyes on Asia: Sanofi expands China footprint; Takeda buys anemia asset Eyes on Asia: Sanofi expands China footprint; Takeda buys anemia asset

byRichard Daverman

Dec 17, 2024

1 Min Read

China on a clock

A growing phenomenon: The rise of biopharma NewCos in China A growing phenomenon: The rise of biopharma NewCos in China

byRichard Daverman

Dec 13, 2024

1 Min Read

Berlin on written wooden block

Bayer expands global incubator network with Germany hub

Bayer expands global incubator network with Germany hub

byMillie Nelson, Editor

Data

To protect the future of healthcare, we need to be data-driven

To protect the future of healthcare, we need to be data-driven

byMillie Nelson, Editor

The ELA'S 2024

LSX awards the crème de la crème of dealmaking

LSX awards the crème de la crème of dealmaking

byMillie Nelson, Editor

Money

Eyes on Asia: GSK’s $300m lupus bet, Pfizer’s $1bn China blast

Eyes on Asia: GSK’s $300m lupus bet, Pfizer’s $1bn China blast

byRichard Daverman, Editor

coloured pencils

Nonprofit looks to bring tomorrow’s science into today’s classrooms

Nonprofit looks to bring tomorrow’s science into today’s classrooms

byMillie Nelson, Editor

Europe’s adversity to risk is why the US is ahead, say experts

Europe’s adversity to risk is why the US is ahead

byMillie Nelson, Editor

Money

Eyes on Asia: VC hits China, BioStar IPO, and Legend splits from GenScript

Eyes on Asia: VC hits China, BioStar IPO, and Legend splits from GenScript

byRichard Daverman, Editor

Eddingpharm reverse-merger ‘breakthrough’ for Hong Kong stock exchange

Eddingpharm reverse-merger ‘breakthrough’ for Hong Kong stock exchange

byRichard Daverman, Editor

Asian currency

Eyes on Asia: Astellas bags gene therapy, AZ a lipoprotein, and a Japanese incubator

Astellas bags gene therapy, AZ a lipoprotein, and a Japanese incubator

byRichard Daverman, Editor

From east to west: Lilly plans incubators in China and UK

From east to west: Lilly plans incubators in China and UK

byMillie Nelson, Richard Daverman

Green leaf with sustainability symbol

Business Strategy

The sustainability series: Reflect, rethink, and reform

The sustainability series: Reflect, rethink, and reform

byMillie Nelson, Editor

Novo’s hunt for genetic med tech drove $600m NanoVation pact

Novo’s hunt for genetic med tech drove $600m NanoVation pact

byMillie Nelson, Editor

Eyes on Asia: News from Sanofi, Bayer, AZ plus the return of VC?

News from Sanofi, Bayer, AZ plus the return of VC?

byRichard Daverman, Editor

Eyes on Asia: Shinyaku’s $735m DMD deal, Kite turns back in China, and more

Shinyaku’s $735m DMD deal, Kite turns back in China, and more

byRichard Daverman, Editor

photo of a sunrise over solar panels/building

Inside five innovative research companies driving progress in oncology and neurology

Driving progress in oncology and neurology

Chinese flag — Photo

China biopharma faces a pause; how bad is it?

China biopharma mid-2023 market summary

byRichard Daverman, Editor

Illustration, Science word. Business concept for Study of physical world structure behavior Experimental research — Illustration

European drug discovery and development players showcase their science at BIO-Europe 2023

European drug discovery and development players showcase their science

Plenary at BIO-Europe in Munich

How industry trends are evolving biotech innovation in 2023

2023 industry trends that helped evolve biotech innovation

three member panel on stage

‘Data matters most’ in biotech, and AI is here to help

‘Data matters most’ in biotech, and AI is here to help

lab testing with vials closeup

Early 2024 review of biotech funding and innovation

Early 2024 review of biotech investment and innovation

photo of panel at BIO Europe Spring 2024

Moving from eminence-based to evidence-based healthcare

Moving from eminence-based to evidence-based healthcare

Eyes on Asia: Eisai $1.5bn pact, OcuMension & Alcon, TYK IPO and more

Eyes on Asia: Eisai $1.5bn pact, OcuMension & Alcon, TYK IPO and more

byRichard Daverman, Editor

Top five Asia biopharma deals: August 2024

Asia biopharma deals: August 2024

byRichard Daverman, Editor

Eyes on Asia: EpimAb sells T-cell, funding for TargetRx, Hygieai on the siRNA march

Eyes on Asia: News from EpimAb, TargetRx, Hygieai

byRichard Daverman, Editor

Eyes on Asia: UCB portfolio sale, Navigator bags $100m, Bora bulks out CDMO biz

Eyes on Asia: UCB portfolio sale, Navigator bags $100m, Bora bulks out CDMO biz

byRichard Daverman, Editor

Eyes on Asia: Mulititude out licenses, Huadong bulks up Abs, Merck and Kelun

Eyes on Asia: Multitude out licenses, Huadong bulks up Abs, Merck and Kelun

byRichard Daverman, Editor

Abu Dhabi Global Healthcare Week

From healthcare to health: 'No country can do this alone,' say experts in UAE

'No country can do this alone,' say experts in UAE

byMillie Nelson, Editor

Mounajro

GLP-1 boom causing pharma players FOMO

GLP-1 boom causing pharma players FOMO

byMillie Nelson, Editor

GSK, Novartis, Calliditas among winners at LSX Awards

GSK, Novartis, Calliditas among winners at LSX Awards

byMillie Nelson, Editor

Subscribe to Our Newsletters

Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.